d-alpha tocopherol has been researched along with Hematologic Malignancies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, A; Kawakami, C; Koh, M; Kuno, T; Takitani, K; Tamai, H | 1 |
| Huff, J | 1 |
2 other study(ies) available for d-alpha tocopherol and Hematologic Malignancies
| Article | Year |
|---|---|
Induction of apoptosis by γ-tocotrienol in human cancer cell lines and leukemic blasts from patients: dependency on Bid, cytochrome c, and caspase pathway.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; BH3 Interacting Domain Death Agonist Protein; Bone Marrow Cells; Caspases; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cells, Cultured; Child; Child, Preschool; Chromans; Cytochromes c; DNA Fragmentation; Female; Hematologic Neoplasms; Humans; Infant; Leukemia; Male; Membrane Potential, Mitochondrial; Mitochondria; Neoplasm Proteins; Vitamin E | 2011 |
Re: Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Animals; Anticarcinogenic Agents; Antioxidants; DNA Damage; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasms; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Rats; Rats, Inbred Strains; Selenium Compounds; Skin Neoplasms; Testicular Neoplasms; Vitamin E | 2004 |